Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews
RAPID REVIEW, 30 October 2020
This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, 46 therapeutic options are examined. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc. You can find the document here.
JUNE ALMEIDA (SCOTLAND, 1930-2007), DISCOVERED THE FIRST CORONAVIRUS IN 1960
June discovered the first coronavirus. Chinese researchers reportedly used her techniques to identify COVID-19. Humanity owes her at least posthumous recognition.
VETERINARY RESEARCH ON COVID-19
École nationale vétérinaire d’Alfort (France): Volatile compounds are collected from the body of a patient with Covid-19 (blood, sweat, skin, and urine samples) and dogs are trained to sense the smell of the virus.
WHO AND THE GLOBAL DEMENTIA OBSERVATORY
The Global Dementia Observatory is an international surveillance platform for policy planners and researchers that will facilitate the monitoring and exchange of information on dementia-related policies, the provision of services, epidemiology and also research.
TECHNOLOGY 5G: UNFORTUNATELY MEDICINE IS NOT THE PRIORITY
In Medicine we are waiting for the advances made with this technology, but the reality is that this is not the priority.
Leading the 5G will allow remote control of a country’s communications and defense systems. In the meantime, we keep thinking about the sick.
In 2019, the US FDA approved a new drug, Rifapentine (which belongs to the Rifamicin family). It is the first approved tuberculosis treatment medicine in more than 40 years.
Professor Ciril Rozman, Leader of internal medicine
He works as a Consulting Doctor in Avda. Diagonal 612, át. 4ª, 08021-Barcelona, Tel. 93-2094192. E-mail:email@example.com
Author of some of the most prestigious internal medicine books. His work is internationally recognized.